These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2164650)

  • 1. Pharmacokinetics, biodistribution and dosimetry of 99Tcm(V)DMSA in humans with squamous cell carcinoma.
    Watkinson JC; Allen S; Lazarus CR; Sinclair J; Blake GM; Clarke SE
    Nucl Med Commun; 1990 May; 11(5):343-59. PubMed ID: 2164650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular biodistribution of 99Tcm(V) DMSA in squamous carcinoma: a comparative study in humans and in an animal tumour model.
    Watkinson JC; Allen S; Higgins M; Bharij A; Lazarus CR; Maisey MN; Clarke SE
    Nucl Med Commun; 1990 Aug; 11(8):547-55. PubMed ID: 2170881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99Tcm (v) DMSA and 67Ga-citrate imaging in patients with head and neck squamous carcinoma: a clinical and scintigraphic study.
    Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
    Nucl Med Commun; 1990 Feb; 11(2):103-10. PubMed ID: 2162508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99Tcm (v) DMSA: the pituitary sign.
    Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
    Nucl Med Commun; 1990 Apr; 11(4):313-7. PubMed ID: 2163501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the optimal imaging time for 99Tcm-(V)-DMSA planar scintigraphy in the detection of squamous carcinoma? A comparative study in humans and in an animal tumour model.
    Watkinson JC; Allen S; Lazarus CR; Maisey MN; Clarke SE
    Nucl Med Commun; 1989 Oct; 10(10):741-50. PubMed ID: 2559379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99Tcm(v)-DMSA planar scintigraphy: does it have a role in the management of patients with head and neck squamous carcinoma?
    Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
    Nucl Med Commun; 1989 Dec; 10(12):859-70. PubMed ID: 2560154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics and biodistribution of technetium-99m(V)dimercaptosuccinic acid in an animal tumor model.
    Watkinson JC; Allen SJ; Laws DE; Lazarus CR; Maisey MN; Clarke SE
    J Nucl Med; 1991 Jun; 32(6):1235-8. PubMed ID: 1646304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99Tcm (v) DMSA: a clinical, planar and SPECT study to evaluate patients with head and neck squamous carcinoma.
    Watkinson JC; Lazarus CR; Mistry R; Maisey MN; Clarke SE
    Nucl Med Commun; 1990 Feb; 11(2):111-20. PubMed ID: 2162509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic squamous carcinoma in the neck: an anatomical and physiological study using CT and SPECT 99Tcm (V) DMSA.
    Watkinson JC; Lazarus CR; Todd C; Maisey MN; Clarke SE
    Br J Radiol; 1991 Oct; 64(766):909-14. PubMed ID: 1659474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99Tcm-diastereomeric dimercaptosuccinic acid complexes: comparison of their biodistribution.
    Awh OD; Kim JR; Shim SC
    Nucl Med Commun; 1989 Jun; 10(6):449-54. PubMed ID: 2549480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the uptake of technetium-99m (v) dimercaptosuccinic acid in patients with squamous carcinoma of the head and neck.
    Watkinson JC; Clarke SE; Shaheen OH
    Clin Otolaryngol Allied Sci; 1987 Dec; 12(6):405-11. PubMed ID: 2832106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of head and neck tumors with technetium(V)-99m DMSA. A new tumor-seeking agent.
    Ohta H; Endo K; Fujita T; Nakashima T; Sakahara H; Torizuka K; Shimizu Y; Ishii Y; Makimoto K; Hata N
    Clin Nucl Med; 1985 Dec; 10(12):855-60. PubMed ID: 3000682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.
    Ohta H; Endo K; Fujita T; Konishi J; Torizuka K; Horiuchi K; Yokoyama A
    Nucl Med Commun; 1988 Feb; 9(2):105-16. PubMed ID: 2838772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m (V) DMSA uptake in amyloidosis.
    Ohta H; Endo K; Kanoh T; Konishi J; Kotoura H
    J Nucl Med; 1989 Dec; 30(12):2049-52. PubMed ID: 2555464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m (v) dimercaptosuccinic acid: a clinical and scintigraphic study in an animal tumour model.
    Watkinson JC; Allen S; Lazarus CR; Laws D; Hibbert J; Clarke SE
    Clin Otolaryngol Allied Sci; 1990 Dec; 15(6):497-501. PubMed ID: 1963580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m(v) dimercaptosuccinic acid planar scintigraphy in head and neck cancer: clinical, scintigraphic and radiological study.
    Watkinson JC; Todd CE; Lazarus CR; Maisey MN; Clarke SE
    J Laryngol Otol; 1990 Oct; 104(10):783-9. PubMed ID: 2174074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99Tcm(V) DMSA: what is its current role in the management of patients with head and neck cancer?
    Watkinson J; Clarke S
    Nucl Med Commun; 1991 Feb; 12(2):79-82. PubMed ID: 1848360
    [No Abstract]   [Full Text] [Related]  

  • 18. The determination of relative kidney function in obstructive uropathy with 99Tcm-DMSA.
    Pauwels EK; Lycklama à Nijeholt AA; Arndt JW; Jonas U
    Nucl Med Commun; 1987 Nov; 8(11):865-7. PubMed ID: 2831485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinetic model for 99mTc-DMSA in the rat.
    Maneval DC; D'Argenio DZ; Wolf W
    Eur J Nucl Med; 1990; 16(1):29-34. PubMed ID: 2155115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentavalent 99Tcm-DMSA imaging in patients with bone metastases.
    Lam AS; Kettle AG; O'Doherty MJ; Coakley AJ; Barrington SF; Blower PJ
    Nucl Med Commun; 1997 Oct; 18(10):907-14. PubMed ID: 9392790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.